Literature DB >> 8808462

Development of a magnetically suspended centrifugal pump as a cardiac assist device for long-term application.

K Nishimura1, C H Park, T Akamatsu, T Yamada, T Ban.   

Abstract

To overcome problems with the shaft seal in conventional centrifugal pumps, the authors have been developing a magnetically suspended centrifugal pump (MSCP) that operates as a valveless, sealless, and bearingless pump. The prototype of the MSCP was modified with respect to size of the volute diffuser and impeller blade profiles. A hemolysis test in vitro using a new version of the MSCP was performed in comparison with a commercially available centrifugal pump. The test circuit for the hemolysis test comprised a blood reservoir, a pump, and polyvinyl tubes, and was filled with fresh heparinized bovine blood. The pumping conditions were a flow rate of 5 L/min and a pump head afterload of 100 mmHg. The index of hemolysis in the MSCP was significantly lower than that in the Biomedicus pump (0.0035 +/- 0.0025 versus 0.0097 +/- 0.0056 g/100 L, p < 0.05). Reduction in the platelet count during pumping also was lower in the MSCP compared with the Biomedicus pump at both 6 hrs and 12 hrs of pumping (p < 0.01). This MSCP may be advantageous for extended use of assist devices, not only from the theoretical point of view, but in a practical sense after the results of the current hemolysis test.

Entities:  

Mesh:

Year:  1996        PMID: 8808462

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  2 in total

1.  Compact, reliable ventricular assist device as a bridge to recovery or for semipermanent use.

Authors:  K Nishimura; S Kono; T Nishina; K Ueyama; A Ikai; T Ikeda; C Nojiri; T Akamatsu; M Komeda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-11

2.  Flow characteristics and required control algorithm of an implantable centrifugal left ventricular assist device.

Authors:  Y Takami; G Otsuka; J Mueller; Y Ohashi; E Tayama; H Schima; H Schmallegger; E Wolner; Y Nosé
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.